Cite
HARVARD Citation
Kurent, T. et al. (n.d.). P686 Neither high infliximab maintenance doses nor high trough levels trigger skin side effects of the drug: a prospective cross-sectional study. Journal of Crohn's and colitis. pp. S463-S464. [Online].